Navigation Links
Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
Date:10/29/2009

BOSTON, Oct. 29 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received purchase orders for its MammoView(TM) line of surgical endoscopy instruments from University of California, San Diego Medical Center, San Diego California. UCSD Medical Center is highly regarded in the industry as it provides a significant amount of healthcare in San Diego. UCSD Medical Center operates a network of outpatient practices, free clinics and community-based services.

UCSD Medical Center was named among the best in the nation in six specialty areas, in addition to possessing eighty physicians who earned a place in San Diego Magazine's 2009 "Physicians of Exceptional Excellence." UCSD Medical Center is home to one of just 39 National Cancer Institute-designated Comprehensive Cancer Centers in the United States. Such centers are prominent among the leading institutions in the nation dedicated to scientific innovation and clinical excellence. UCSD is the only Comprehensive Cancer Center in San Diego and Imperial counties to have earned this honor.

"We are extremely pleased to be a supplier to such a distinguished medical institution that is one of the top health care providers in the United States. We believe that our MammoView line will be instrumental in serving UCSD Medical Center wellness initiatives," stated Bob Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy recently announced that the Company has taken the initial steps to get the CE Marking for its FDA approved MammoView(TM) line of surgical instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU), which represents 30% or $94 Billion of the worldwide demand for medical instruments.

For more information on UCSD Medical Center, please visit: www.ucsd.edu

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office with its catalog of FDA Approved products. Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

SOURCE Solos Endoscopy, Inc.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Receives Additional Purchase Orders from National Cancer Institute and National Institute of Health for its MammoView(TM) Product Line
2. Solos Endoscopy, Inc. Receives Multiple Purchase Orders for its MammoView(TM) Product Line
3. Solos Endoscopy, Inc.s FDA Approved MammoView(TM) Product Line to Obtain CE Mark
4. Solos Endoscopy, Inc.s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress
5. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
6. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
7. Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair(R) System for Severe Asthma
8. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
9. Lumenis Receives 510K Clearance for the PolyScope Disposable Flexible Endoscope
10. Dr. Mark Popovsky Receives Prominent Award for Leadership in Transfusion Medicine
11. Pharmalink AB Receives Patent for Nefecon(R) Principle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... is actively feeding the Frederick area economy by obtaining investment capital for emerging ... the past 2½ years that have already resulted in more than a million ...
Breaking Medicine News(10 mins):